🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — November 2025 Page 5

Mounjaro KwikPen vs vial — November 2025

bbq_ray_KC Mon, Oct 20, 2025 at 8:54 AM 24 replies 1,352 viewsPage 5 of 5
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Oct 27, 2025 at 10:59 AM#21
quinn_sf said:
One habit that pays for itself: post the method alongside the number.

Bookmarking. The distinction being drawn above is the one nobody else makes. Sending this to two other people who asked me the same thing last week.

40 15lucas_SP_BR, lisa_labSD, adam_van and 37 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Oct 29, 2025 at 4:25 AM#22

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

39 14sarah_nash92, FitDadDave, RunnerRach and 36 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Oct 30, 2025 at 9:52 PM#23
Dr.AddMedPHL said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Second this.

38 13bri_stats, pete_manc_UK, anna.melb_AU and 35 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Nov 1, 2025 at 3:20 PM#24
Dr.AddMedPHL said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Adding the part of the answer the thread has not reached. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Nov 1, 2025 at 4:20 PM
37 12Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 34 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Nov 3, 2025 at 8:49 AM#25

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Nov 3, 2025 at 1:49 PM
36 11Dr.EndoEP, GraceAZ_72, carl_compliance and 33 others
Reply Quote Save Share Report
1345

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register